Benjamin Everhart
About Benjamin Everhart
Benjamin Everhart is an Associate Scientist in Cancer Biology at Bristol Myers Squibb, with a background in biomedical engineering and research experience from Dana-Farber Cancer Institute and Binghamton University.
Current Role at Bristol Myers Squibb
Benjamin Everhart is currently employed at Bristol Myers Squibb as an Associate Scientist specializing in Cancer Biology. He began his tenure in April 2021 and contributes his expertise in Polymerase Chain Reaction (PCR) and Flow Cytometry to advance cancer research.
Experience at Dana-Farber Cancer Institute
Before joining Bristol Myers Squibb, Benjamin Everhart worked at Dana-Farber Cancer Institute as a Research Technician. His tenure lasted for 7 months, from 2020 to 2021. During his time there, he was involved in important research projects in Boston, Massachusetts.
Business Development Role at United By Blue
Prior to his role in cancer biology research, Benjamin gained experience in a business development capacity. In 2020, he worked for 5 months as a Business Development Representative at United By Blue, where he focused on company growth and strategic initiatives.
Academic Background at Binghamton University
Benjamin Everhart holds a Bachelor of Science in Biomedical Engineering from Binghamton University. He studied from 2017 to 2020, during which he gained substantial research experience. Notable roles included working as an Undergraduate Research Assistant at the Thomas J. Watson School of Engineering and Applied Science, where he served for 2 years.
Technical Expertise and Research Skills
Benjamin Everhart brings a strong technical skill set to his roles, particularly in Polymerase Chain Reaction (PCR), Flow Cytometry, and Cell Culture techniques. His extensive background in academic research has further honed his analytical and experimental abilities, making significant contributions to his current and past positions.